- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03418103
System to Avoid Fall Events (SAFE)
System to Avoid Fall Events: A Descriptive Comparison Study Evaluating the Quantitative Impact of Using Thermal Imaging to Monitor At-risk Patients.
Rinicare Ltd, a Lancaster-based SME, and University Hospitals of Morecambe Bay Trust (UHMB) will collaborate on a research study to determine the feasibility, suitability, and acceptability of the Rinicare developed SAFE (System to Avoid Fall Events) fall prevention and detection system in a hospital environment. The study is designed to determine if the implementation of the SAFE system will help clinicians to prevent in-patient falls from hospital beds. In-patient falls are a serious problem with more than 245,000 incidents reports in 2015-2016. 77% of these falls involve a patient over the age of 65, and the injuries patients suffer due to falls is estimated by NICE to cost the NHS £2.3B annually. This study will test the performance of the SAFE technologies against the current interventions to prevent falls, and it will investigate the impact of the SAFE technology on the workflow of the carers.
The SAFE study is designed as a comparison study combining a descriptive, quantitative methodology measuring the number of fall events with a normative analysis of the qualitative aspects experienced by the clinicians using the SAFE system during the project period.
The primary research objective of this study is to determine if the implementation of the SAFE system will quantifiably reduce the number of fall events in the ward compared to a similar control period. The secondary research objective is to determine if the SAFE system has a positive or a negative impact on the ward staff's workflow, i.e. the ability of the ward staff to provide care to the patients.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Patients who are deemed by the ward clinicians to be at risk of falling from the bed due to one or more of the following reasons:
- Frailty due to old age (E.g. 65 years or older)
- Frailty due to medical conditions (E.g. hypotension)
- Frailty due to mental conditions (E.g. dementia)
- Frailty due to physical conditions (E.g. amputation or injury)
- Frailty due to medication(s)
Patients who are able to give informed consent will be included. In addition, any patients who are unable to consent to participation in this study due to a lack of mental capacity but are assessed by the ward matron to benefit from participation in this study will also be included. Where possible, consent will be obtained from close relatives or legal guardians in this case. These patients are a particularly vulnerable group and their interests must therefore be protected. They should be given the same opportunities to participate in ethically designed research projects as those who do not lack capacity but must not be put at unwarranted risk.
Exclusion Criteria:
Patients under 18 years of age Patients who are in an unconscious or comatose state, physically restrained to the bed, or otherwise completely unable to move under their own power and thus not at risk of falling out of their bed
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of falls recorded
Time Frame: 12 months
|
The number of falls and fall related incidents in the ward
|
12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Kim Wilson, BA (Hons), University Hospitals of Morecambe Bay NHS Trust
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 999
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Accidental Fall
-
Aalborg University HospitalCompleted
-
University of AmsterdamCompletedDeprescribing | Fall | Fall Injury | Fall Patients | Accidental FallNetherlands
-
Rush University Medical CenterWestern Michigan UniversityCompletedFall, Accidental | Fall AccidentUnited States
-
Betul Esra CevikCompletedAccidental Fall | Fall Prevention | Fall Risk FactorsTurkey (Türkiye)
-
CUSH Health Ltd.University of SussexNot yet recruitingAccidental Fall
-
Virginia Polytechnic Institute and State UniversityCompleted
-
National Opinion Research CenterCenters for Disease Control and Prevention; Emory HealthcareCompleted
-
Escola Superior de Tecnologia da Saúde de CoimbraSensing Future Technologies; Fraunhofer Portugal Research Center for Assistive...UnknownAccidental FallPortugal
-
MedicusTek, IncCompletedPatient Fall | Accidental Fall From BedTaiwan
-
University of PalermoCompleted
Clinical Trials on Thermal imaging analysis of participant position in a hospital bed
-
Szeged UniversityNot yet recruiting
-
Zhejiang Cancer HospitalFudan University; Cancer Institute and Hospital, Chinese Academy of Medical... and other collaboratorsCompletedStage III Non-small-Cell Lung CancerChina
-
Hacettepe UniversityCompletedQuality of Life | Physical Disability | Psychosocial Problem | Meniere DiseaseTurkey
-
Children's Oncology GroupRecruitingStage I Mixed Cell Type Kidney Wilms Tumor | Stage II Mixed Cell Type Kidney Wilms Tumor | Stage III Mixed Cell Type Kidney Wilms Tumor | Stage IV Mixed Cell Type Kidney Wilms TumorUnited States, Canada, Australia
-
National Cancer Institute (NCI)RecruitingNeuroblastoma | Ganglioneuroblastoma, NodularUnited States, Canada, Puerto Rico, Australia, New Zealand
-
NRG OncologyRecruitingStage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Locally Advanced Unresectable Pancreatic Ductal AdenocarcinomaUnited States